In this cohort study of 253 subjects with ischemic stroke, we demonstrated that baseline circulating LCN2 levels were positively associated with the development of END and 90‐day poor functional outcome, which remained statistically significant after adjustment for important prognostic covariates of stroke. This evidence concerns the gene LCN2 and Stroke.